Junpei Soeda

Company: Takeda Pharmaceutical

Job title: Head Japan Medical Affairs

Seminars:

Future of Liquid Biopsy from PARADIGM Study to Inform Patient Selection 11:30 am

Overview of Liquid biopsy (ctDNA testing) Utility case of liquid biopsy based on PARADIGM study to describe validated and adequately sensitive plasma ctDNA assay may inform appropriate selection of patients for frontline metastatic colorectal cancer patients Limitation and future perspective of liquid biopsy in clinical practiceRead more

day: Conference Day 2